🟢 GRAIL is trading 4.8% up today as immediate catalyst remains unclear

GRAIL is trading 4.8% up at $77.48, while the immediate catalyst remains unclear.

• No new company-specific announcement dated August 20, 2026, was identified that clearly explains the move.
• The latest material catalyst is the FDA advisory committee meeting scheduled for September 23 to review Galleri’s premarket approval application, previously associated with a share-price increase.
• GRAIL is outperforming the broader market and biotech sector.